Positive New Data from Phase 1/2 Trial of AT-01 (Iodine

AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific...

Related Keywords

Canada ,Vancouver ,British Columbia ,San Francisco ,California ,United States ,Emily Martin ,Luke Heagle ,Attralus Inc ,University Of Tennessee Research Foundation ,Society Of Nuclear Medicine Molecular Imaging ,University Of Tennessee Graduate School Medicine ,Cancer Theranostics Program ,Tennessee Graduate School ,Nuclear Medicine ,Molecular Imaging ,Annual Meeting ,Imaging Results ,Oral Presentation ,Final Results ,First In Human Study ,Amyloid Reactive Peptide ,Iodine Evuzamitide ,Systemic Amyloidosis ,Jonathan Wall ,Distinguished Professor ,Integrated Session ,Cardiac Amyloidosis ,Systemic Amyloidosis Using ,Identifies Organ Specific ,Amyloid Regression ,Associate Professor ,Meet The Author Poster Hall Reception ,Tennessee Research ,Attralus ,Nc ,Snmmi ,Amyloidosis ,Iagnostic ,